Status:
TERMINATED
Genetic Disease Gene Identification
Lead Sponsor:
State University of New York - Upstate Medical University
Conditions:
Congenital Vertical Talus
Familial Encephalopathy With Neuroserpin Inclusion Bodies
Eligibility:
All Genders
6+ years
Brief Summary
This is a a study to identify inherited disease genes. The study will use molecular techniques to map genetic diseases using techniques such as Affymetrix SNP chips. The powerful combination of the in...
Detailed Description
It is proposed to identify and recruit individuals and/or families with specified the disorders listed above. 10-20 ml (2-4 teaspoons) of peripheral blood will be collect¬ed from all adult subjects. S...
Eligibility Criteria
Inclusion
- Patients and their families identified by physicians.
Exclusion
- Patients with unrelated disorders.
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT00916903
Start Date
October 1 2005
End Date
July 1 2015
Last Update
January 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SUNY Upstate Medical University
Syracuse, New York, United States, 13210